DrugPatentWatch Archives
You are currently viewing the 2007 archives
Click here to return to the current data set
Click here to return to the current data set
|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Clinical Trials for: hexa
First 100 trials shown — repeat this search at ClinicalTrials.gov| Title | Status | Condition | Last Changed | External link |
|---|---|---|---|---|
| V260 Study: Concomitant Use of V260 and INFANRIXâ„¢ Hexa in Healthy Infants (V260-010)(COMPLETED) | Completed | Rotavirus Disease | October 7, 2010 | link |
| Study of the Booster Effect of DTaP-IPV-Hep B-PRP-T Combined Vaccine or Infanrix Hexaâ„¢ and Prevenarâ„¢ in Healthy Infants | Active, not recruiting | Diphtheria; Tetanus; Whooping Cough; Hepatitis B; Poliomyelitis | February 5, 2013 | link |
| Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexaâ„¢ (DTPa-HBV-IPV/Hib) Vaccine | Completed | Diphtheria; Hepatitis B; Haemophilus Influenzae Type b Disease; Poliomyelitis; Pertussis; Tetanus | April 18, 2013 | link |
| Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants | Completed | Hepatitis B; Polio; Diphtheria; Pertussis; Haemophilus Influenzae Type b | September 30, 2011 | link |
| Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly | Completed | Varicella; Measles; Mumps; Rubella; Diphtheria; Tetanus; Pertussis; Poliomyelitis; Hepatitis B; Haemophilus Infections | April 3, 2009 | link |
| Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13® | Completed | Pneumococcal Vaccines | February 15, 2013 | link |
| Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants | Completed | Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type B; Hepatitis B | January 20, 2010 | link |
| Comparison of Immunogenicity and Reactogenicity of INFANRIXâ„¢ HEXA and HEXAVACâ„¢ Vaccines as a Primary Vaccination Course | Completed | Hepatitis B; Diphtheria; Haemophilus Influenzae Type b (Hib); Poliomyelitis; Pertussis; Tetanus | October 20, 2011 | link |
| Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexaâ„¢ Versus Individual Administration of Each Vaccine | Completed | Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Meningococcal Disease; Tetanus | November 1, 2012 | link |
| Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexaâ„¢ or Infanrix-IPV/Hibâ„¢ | Completed | Poliomyelitis; Diphtheria; Hepatitis B; Haemophilus Influenzae Type b Disease; Pertussis; Tetanus | May 16, 2013 | link |
| Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects | Completed | Haemophilus Influenzae Type b Disease; Meningococcal Serogroup Diseases | May 21, 2009 | link |
| A Phase I Study of Pyrimethamine in Patients With GM2 Gangliosidosis | Withdrawn | G(M2) Ganglioside; Tay-Sachs Disease Ganglioside; Sandhoff Disease Ganglioside | February 21, 2013 | link |
| Spanish Mixed HEXA/PENTA/HEXA Schedule | Recruiting | Neisseria Meningitidis; Bacterial Infections; Virus Diseases | June 14, 2013 | link |
| Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar® | Completed | Infant; Healthy | April 13, 2012 | link |
| Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine | Completed | Haemophilus Influenzae Type b Disease; Meningococcal Serogroup Diseases | June 7, 2012 | link |
| Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC | Completed | Haemophilus Influenzae Type b Disease; Meningococcal Serogroup C Diseases | November 10, 2011 | link |
| Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam | Completed | Pneumococcal Disease | July 23, 2012 | link |
| Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants | Completed | Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Tetanus | April 25, 2013 | link |
| Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa | Completed | Vaccines, Pneumococcal; Infant; Fever, Chemically Induced; Drug Therapy, Combination | February 20, 2013 | link |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age | Completed | Pneumococcal Disease | June 14, 2012 | link |
| Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children | Completed | Diphtheria; Tetanus; Pertussis; Hepatitis B; Poliomyelitis; Haemophilus Influenzae Type b Disease | October 15, 2009 | link |
| Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines | Completed | Fever | September 29, 2011 | link |
| Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children | Completed | Hepatitis B | July 19, 2012 | link |
| Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age | Completed | Poliomyelitis; Hepatitis B; Diphtheria; Pertussis; Haemophilus Infection; Tetanus | September 29, 2011 | link |
| A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA | Completed | Hepatitis B | November 17, 2010 | link |
| Vaccination of Children Following Allogeneic Stem Cell Transplantation | Completed | Allogeneic Haematopoietic Stem Cell Transplantation | June 6, 2012 | link |
| Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A | Completed | Pneumococcal and Meningococcal Diseases. | May 3, 2012 | link |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age | Completed | Pneumococcal Disease; Streptococcus Pneumoniae Vaccines | January 5, 2012 | link |
| Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) | Active, not recruiting | Bacterial Infections; Virus Diseases | April 9, 2013 | link |
| Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) | Completed | Bacterial Infections; Virus Diseases | April 9, 2013 | link |
| Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). | Completed | Prophylaxis of DTPa-HBV-IPV-Hib & MenC Diseases | July 22, 2009 | link |
| 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age | Completed | Meningococcal Infection; Haemophilus Infection | June 15, 2012 | link |
| Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis | Active, not recruiting | Gangliosidoses GM2 | March 11, 2010 | link |
| Pyrimethamine as a Treatment for Late-Onset GM2-gangliosidosis (Tay-Sachs and Sandhoff Disease) | Completed | Gangliosidoses, GM2; Sandhoff Disease; Tay-Sachs Disease | February 22, 2012 | link |
| Pharmacokinetics, Safety and Tolerability of Zavesca (Miglustat) in Patients With Infantile Onset Gangliosidosis: Single and Steady State Oral Doses | Completed | GM2 Gangliosidoses; Tay-Sachs; Sandhoff Disease | May 5, 2008 | link |
| Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines | Active, not recruiting | Meningococcal Serogroup A, C, W-135 and Y Diseases | May 30, 2013 | link |
| A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenarâ„¢ and Rotarixâ„¢ in Healthy Latin American Infants | Completed | Diphtheria; Tetanus; Whooping Cough; Hepatitis B; Poliomyelitis | December 12, 2011 | link |
| Study of the DTacP-IPV-HepB-PRP-T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexaâ„¢ | Completed | Diphtheria; Tetanus; Pertussis; Hepatitis B; Poliomyelitis; Haemophilus Influenzae Type B | January 20, 2010 | link |
| Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines | Active, not recruiting | Haemophilus Influenzae Type b Disease; Pneumococcal Disease; Hepatitis B Disease; Persistence of Immunogenicity; Meningococcal Disease | November 21, 2012 | link |
| Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine | Completed | Diphtheria; Tetanus; Whooping Cough; Hepatitis B; Poliovirus; Meningitis | September 29, 2009 | link |
| Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule | Completed | Streptococcus Pneumoniae and Nontypable Haemophilus Influenzae; Streptococcus Pneumoniae Vaccines | November 21, 2012 | link |
| Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose | Completed | Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Serogroup C Meningococcal Diseases; Diphtheria; Pertussis; Tetanus | December 1, 2011 | link |
| Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine | Withdrawn | Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Pneumococcal Diseases; Tetanus | February 24, 2011 | link |
| Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines | Completed | Pneumococcal Disease.; Meningococcal Disease.; Streptococcus Pneumoniae Vaccines | August 2, 2012 | link |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age | Completed | Pneumococcal Disease; Streptococcus Pneumoniae Vaccines | January 22, 2011 | link |
| Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately | Completed | Hepatitis B; Diphtheria; Haemophilus Influenzae Type b (Hib); Poliomyelitis; Pertussis; Tetanus | October 20, 2011 | link |
| Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly | Completed | Hepatitis B; Diphtheria; Haemophilus Influenzae Type b (Hib); Poliomyelitis; Pertussis; Tetanus | October 20, 2011 | link |
| Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine | Completed | Hepatitis B; Diphtheria; Haemophilus Influenzae Type b (Hib); Poliomyelitis; Pertussis; Tetanus | October 20, 2011 | link |
| Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule | Completed | Pneumococcal Infections | November 21, 2012 | link |
| NeisVac-C Single Prime Study in Infants | Completed | Neisseria Meningitidis | July 11, 2012 | link |
| Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children | Completed | Hepatitis B | January 12, 2012 | link |
| Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) | Completed | Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Tetanus | May 2, 2013 | link |
| Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants | Completed | Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B; Serogroup C Meningococcal Diseases; Diphtheria; Pertussis; Pneumococcal Diseases; Tetanus | May 2, 2013 | link |
| Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants | Completed | Diphtheria; Tetanus; Pertussis; Hepatitis B; Poliomyelitis | January 11, 2010 | link |
| Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants | Active, not recruiting | Haemophilus Influenzae; Streptococcus Pneumoniae | February 28, 2013 | link |
| A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine | Completed | Pneumococcal Disease | November 21, 2012 | link |
| Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers | Completed | Meningococcal Meningitis | February 1, 2013 | link |
| Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age | Completed | Poliomyelitis; Hepatitis B; Diphtheria; Haemophilus Influenzae Type b; Pertussis; Pneumococcal Diseases; Serogroup C Meningococcal; Rotavirus; Tetanus | December 8, 2011 | link |
| Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants | Completed | Pneumococcal Disease | September 25, 2009 | link |
| Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. | Terminated | Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B; Serogroup C Meningococcal Diseases; Diphtheria; Pertussis; Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccines; Tetanus | November 16, 2012 | link |
| COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & AOM Efficacy Study of the Pneumococcal Conjugate Vaccine | Completed | Pneumonia & AOM Caused by S. Pneumoniae & H. Influenzae | August 18, 2011 | link |
| Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment | Completed | Streptococcus Pneumoniae; Pneumococcal Disease | April 25, 2013 | link |
| To Evaluate Immunogenicity & Safety of GSK Bio’s DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines | Completed | Diphtheria; Tetanus; Pertussis; Hepatitis B; Polio; Haemophilus Influenzae Type B | October 18, 2006 | link |
| Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine | Completed | Pneumococcal Disease | September 20, 2012 | link |
| Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib | Completed | Pneumococcal Disease; Haemophilus Infection | November 17, 2011 | link |
| Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. | Completed | Prophylaxis Pneumococcal Vaccine | November 21, 2012 | link |
| Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants | Completed | Pneumococcal Disease; Haemophilus Influenza Infections | May 30, 2013 | link |
| Study to Evaluate GlaxoSmithKline (GSK) Biologicals’ MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants | Completed | Meningitis, Haemophilus | November 23, 2006 | link |
| Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Mths and 3-5 Yrs Old | Completed | Meningococcal Serogroup Diseases | November 3, 2011 | link |
| Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine | Completed | Diphtheria, Tetanus, Pertussis, Hepatitis B, Polio, Haemophilus Influenzae Type B | September 29, 2011 | link |
| A Natural History Study of Hexosaminidase Deficiency | Recruiting | Tay-Sachs Disease, Sandhoff Disease, Late Onset Tay-Sachs Disease | May 28, 2013 | link |
| Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge | Completed | Hepatitis B | April 12, 2012 | link |
| Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants. | Completed | Vaccines, Pneumococcal | June 28, 2012 | link |
| Fetal Umbilical Cord Blood (UCB) Transplant for Lysosomal Storage Diseases | Recruiting | Lysosomal Storage Diseases; Inborn Errors of Metabolism | May 8, 2013 | link |
| Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose | Completed | Pneumococcal Disease; Haemophilus Influenzae Infections | June 14, 2012 | link |
| Gene Therapy for Tay-Sachs Disease | Recruiting | Tay-Sachs Disease; Sandhoff Disease; Late Onset Tay-Sachs Disease | May 30, 2013 | link |
| Renoprotection by Pentoxifylline and Valsartan in Chronic Kidney Disease (CKD) | Recruiting | Chronic Renal Failure | December 26, 2012 | link |
| Effect of Fenofibrate on Kidney Function: a Six-Week Randomized Cross-Over Trial in Healthy People | Completed | Healthy Volunteers | October 12, 2007 | link |
| A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects | Completed | Infections, Human Immunodeficiency Virus and Tuberculosis | June 7, 2012 | link |
| Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) | Completed | Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Tetanus | May 2, 2013 | link |
Source: ClinicalTrials.gov
This preview shows a limited data set. Complete access is available with a Subscription
« Back to Dashboard
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc
